Maybe a colleague at the office suddenly swapped their teh tarik for kopi-o kosong and dropped noticeable weight, or you've scrolled past "Ozempic" trending online next to celebrity photos. It's a real prescription medicine with a specific job in the body, not a shortcut — here's what it actually does.
Ozempic is the brand name for semaglutide, a once-weekly injectable medicine. Ozempic contains the active ingredient semaglutide and is given once weekly by subcutaneous injection using a prefilled pen. It was first approved to help adults with type 2 diabetes manage their blood sugar, and later shown to lower the risk of major cardiovascular problems in people who already have heart disease.
Ozempic belongs to a class of medicines called GLP-1 receptor agonists. Glucagon-like peptide-1 (GLP-1) is a natural hormone that is released by your gut after a meal. Semaglutide is essentially a lab-made, longer-lasting version of that same hormone, engineered to keep working far beyond the short window a natural hormone would last in the body.
You may also have heard of Wegovy or Rybelsus. Semaglutide is sold under the brand names Ozempic, Rybelsus, and Wegovy, and while they share the same active ingredient, each is approved for a slightly different use and dose — Ozempic for diabetes, Wegovy specifically for weight management. Ozempic is not used for type 1 diabetes, and it's not typically prescribed for people who have had pancreatitis in the past. This distinction matters in a region like Singapore and Malaysia, where the prevalence of diabetes in Singapore is among the highest within Southeast Asia at 13.7% versus a regional prevalence of 8.5%, making accurate use of these medicines genuinely important rather than a passing trend.
Ozempic's core job is helping the pancreas release more insulin exactly when it's needed — right after a meal, when blood sugar starts climbing. GLP-1 agonists mimic the way a hormone called glucagon-like peptide 1 works in the body: when blood sugar starts to rise after a person eats, these medicines cause the body to make more insulin, and the extra insulin helps lower blood sugar. This glucose-dependent action is why it's often paired with diet changes, exercise, or other diabetes medicines like metformin rather than replacing them entirely.
For people with type 2 diabetes who already have cardiovascular disease, clinical trials found real protective effects beyond blood sugar numbers. A significant reduction in major cardiovascular events was revealed, including cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke, among T2DM patients in the SUSTAIN-6 trial. This is a major reason Ozempic is prescribed specifically to people with established heart disease, not just those with high blood sugar alone.
Because GLP-1 also slows how quickly food leaves the stomach and signals fullness to the brain, many people naturally eat less on Ozempic. This can decrease hunger and may lead to weight loss, and in general, all GLP-1 agonists can help with weight loss. For the Ozempic brand specifically, weight loss is considered a welcome side benefit rather than the primary approved use — that role belongs to the higher-dose Wegovy version.
In people who have both type 2 diabetes and chronic kidney disease, Ozempic has an additional approved use. It can help prevent the risk of kidney disease progression and cardiovascular death in adults with type 2 diabetes and chronic kidney disease. This makes it a multi-purpose option for people managing several overlapping conditions at once, rather than a single-issue fix.
Ozempic is injected just under the skin of the belly, thigh, or upper arm, rather than swallowed. This matters because semaglutide is a peptide — a small protein-like molecule — and stomach acid would normally break it apart before it could do anything useful, the same way your body digests protein from food.
To get around this, the semaglutide molecule is chemically modified with a fatty acid tail that binds to a protein in the blood called albumin. GLP-1 drugs require administration by mostly weekly subcutaneous injections of modified peptides with fatty acid alterations that allow for an extended half-life. This binding protects the hormone-like molecule from being broken down quickly, which is exactly what allows a single shot to keep working for about a week instead of needing a daily dose.
There's also an oral tablet version, Rybelsus, which pairs semaglutide with an absorption-helper ingredient so a small amount can pass through the stomach lining before being digested. The tablets contain an ingredient called SNAC that passes into breast milk, while the injection form of Ozempic does not contain SNAC. This is why the tablet must be taken on an empty stomach with minimal water to work properly, unlike the once-weekly injection.
The most common side effects are digestive. Gastrointestinal symptoms — nausea, vomiting, diarrhea, and constipation — are by far the most common side effects of GLP-1 drugs, especially when starting out or stepping up the dose, and these usually ease with time as the body adjusts.
Less common but more serious risks include inflammation of the pancreas and gallbladder problems. Some people taking Ozempic have developed gallstones or gallbladder inflammation called cholecystitis, and it shouldn't be used in people with a history of gallbladder disease. There's also a rare chance of worsening diabetic eye disease if blood sugar improves very quickly, and anyone with a personal or family history of certain thyroid cancers is usually screened first. In tests of Ozempic and similar drugs in mice, some mice developed thyroid tumours, so anyone with a personal or family history of thyroid cancer should discuss it with their doctor before starting.
Ozempic tablets specifically are generally avoided during breastfeeding because of the SNAC ingredient mentioned earlier, and it isn't approved for type 1 diabetes. The use of semaglutide is contraindicated in people with type 1 diabetes mellitus, renal insufficiency, acute pancreatitis, and diabetic gastroparesis. A history of slow stomach emptying or pancreas problems is another reason a doctor may choose a different medicine.
Because it's a prescription medicine, Ozempic should only be used under medical supervision — never shared, and never bought from unverified online sellers. Health products bought online from unfamiliar sources may be illegal, counterfeit, or substandard, and may contain potent ingredients which can harm your health. Singapore's HSA has repeatedly flagged this exact risk for GLP-1 medicines sold outside licensed clinics and pharmacies.
No food replaces a prescribed medicine, but it helps to know your gut already makes GLP-1 on its own — certain eating habits support that natural process, especially useful if kiasu health-tracking has you looking for small daily wins:
Ozempic is a genuine medical tool built for managing type 2 diabetes, not a lifestyle hack, and it works best alongside — not instead of — everyday habits like sensible hawker choices, regular movement, and good sleep. In a region where diabetes rates keep climbing and health optimisation culture runs strong, it's worth remembering that the decision to use it isn't a productivity choice; it's a medical one, made with a doctor who knows your full health history rather than a trend seen on social media.
This article is for general informational purposes and is not a substitute for professional medical advice. Please consult a qualified healthcare professional before making any changes to your diet or supplement routine.
Ask Elaine how this applies to your goals and routine — free, no pressure.